Clinical trial
A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken…
NCT00004580 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00004580 |
|---|---|
| Title | A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors |
| Official title | Phase I/II Study of ABT-378/Ritonavir in Protease Inhibitor Experienced HIV-Infected Patients |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Lopinavir/Ritonavir, Nevirapine |
| First posted | Aug 31, 2001 |
| Last update posted | Feb 20, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: